Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Goldsmith

Showing results (11-20 of 188) with videos related to

Pageof 19
Sort By:
Drug Safety|January 21, 2011
Mammalian target of rapamycin (mTOR) inhibitors: potential uses and a review of haematological adverse effectsSofia Sofroniadou, David Goldsmith
The New England Journal of Medicine|March 6, 2007
Chronic kidney disease, anemia, and epoetinAshraf Mikhail, David Goldsmith
Journal of Nephrology|June 9, 2007
Biosimilars: uncharted territoryFrancesco Locatelli, David Goldsmith
Current Opinion in Cardiology|June 9, 2012
Statins and kidney disease: is the study of heart and renal protection at the cutting edge of evidence?Mark Jenkins, David Goldsmith
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 5, 2010
Time to Reconsider Evidence for Anaemia Treatment (TREAT) = Essential Safety Arguments (ESA)David Goldsmith, Adrian Covic
F1000 Medicine Reports|October 16, 2010
Renin angiotensin aldosterone system (RAAS) inhibitors in the prevention of early renal disease in diabetesLuigi Gnudi, David Goldsmith
Clinical Nephrology|July 15, 2014
Oral phosphate binders in CKD - is calcium the (only) answer?David Goldsmith, Adrian Covic
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 26, 2009
Blood pressure control in CKD stage 5D patients--are we more or less certain what to do in 2009?David Goldsmith, Adrian Covic
The International Journal on Drug Policy|April 8, 2019
The lack of focus on trans women in a themed issue of the International Journal of Drug Policy on sexualised drug useDavid Goldsmith, Miriam Hillyard
American Heart Journal|December 17, 2013
Reply to JolobeDavid Goldsmith, Camus Nimmo
Pageof 19

Showing results (11-20 of 188) with videos related to

Sort By:
Pageof 19
Drug Safety|January 21, 2011
Mammalian target of rapamycin (mTOR) inhibitors: potential uses and a review of haematological adverse effectsSofia Sofroniadou, David Goldsmith
The New England Journal of Medicine|March 6, 2007
Chronic kidney disease, anemia, and epoetinAshraf Mikhail, David Goldsmith
Journal of Nephrology|June 9, 2007
Biosimilars: uncharted territoryFrancesco Locatelli, David Goldsmith
Current Opinion in Cardiology|June 9, 2012
Statins and kidney disease: is the study of heart and renal protection at the cutting edge of evidence?Mark Jenkins, David Goldsmith
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 5, 2010
Time to Reconsider Evidence for Anaemia Treatment (TREAT) = Essential Safety Arguments (ESA)David Goldsmith, Adrian Covic
F1000 Medicine Reports|October 16, 2010
Renin angiotensin aldosterone system (RAAS) inhibitors in the prevention of early renal disease in diabetesLuigi Gnudi, David Goldsmith
Clinical Nephrology|July 15, 2014
Oral phosphate binders in CKD - is calcium the (only) answer?David Goldsmith, Adrian Covic
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 26, 2009
Blood pressure control in CKD stage 5D patients--are we more or less certain what to do in 2009?David Goldsmith, Adrian Covic
The International Journal on Drug Policy|April 8, 2019
The lack of focus on trans women in a themed issue of the International Journal of Drug Policy on sexualised drug useDavid Goldsmith, Miriam Hillyard
American Heart Journal|December 17, 2013
Reply to JolobeDavid Goldsmith, Camus Nimmo
Pageof 19